September 6, 2022 — Stopping statin treatment early could substantially reduce lifetime protection against heart disease ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
September 6, 2022 — Smokers have weaker hearts than non-smokers, according to research presented at ESC Congress 2022.1 ...
September 6, 2022 — Research presented at ESC Congress 2022 supports a causal relationship between air pollution and ...
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
September 2, 2022 — A restrictive oxygenation target in comatose patients resuscitated after out-of-hospital cardiac ...
September 2, 2022 — Dapagliflozin reduces the risk of cardiovascular death or worsening heart failure in heart failure ...
September 2, 2022 — Acetazolamide added to intravenous loop diuretics decreases congestion within three days in patients ...
September 2, 2022 — A randomized trial in more than 45,000 men has suggested that cardiovascular screening including car ...
September 2, 2022 — In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was ...
September 2, 2022 — In patients undergoing echocardiographic evaluation of cardiac function, preliminary assessment by a ...
September 2, 2022 — Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospit ...
September 1, 2022 — “At ESC Congress in Barcelona, we discussed the newest science in the light of our collective ...
September 1, 2022 — A target blood pressure of 77 mmHg provides no benefit to survival or neurological outcome in ...
September 1, 2022 — The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial ...
August 30, 2022 — Abbott announced new late-breaking data that show its HeartMate 3 heart pump extends survival of advan ...
August 29, 2022 — Detailed results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) ...